Amicus Therapeutics Inc
FOLD
Market Cap$3.09B
Close$
$12.62
21% upside
Current Fair Value
21% upsideUndervalued by 21% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.09 Billion |
|---|---|
| Enterprise Value | $3.19 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.51 |
| Beta | 1.13 |
| Outstanding Shares | 296,176,419 |
| Avg 30 Day Volume | 2,715,986 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -20.38 |
|---|---|
| PEG | 51.7 |
| Price to Sales | 10.43 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7.99 |
| Enterprise Value to EBIT | -43.42 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 2.42 |
Revenue Sources
No data
ESG Score
No data
About Amicus Therapeutics Inc
CEO: John Crowley